1. Home
  2. TAIT vs BCDA Comparison

TAIT vs BCDA Comparison

Compare TAIT & BCDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TAIT
  • BCDA
  • Stock Information
  • Founded
  • TAIT 1989
  • BCDA N/A
  • Country
  • TAIT United States
  • BCDA United States
  • Employees
  • TAIT N/A
  • BCDA N/A
  • Industry
  • TAIT Electronic Components
  • BCDA Biotechnology: Pharmaceutical Preparations
  • Sector
  • TAIT Technology
  • BCDA Health Care
  • Exchange
  • TAIT Nasdaq
  • BCDA Nasdaq
  • Market Cap
  • TAIT 15.1M
  • BCDA 13.7M
  • IPO Year
  • TAIT 1995
  • BCDA N/A
  • Fundamental
  • Price
  • TAIT $1.07
  • BCDA $1.27
  • Analyst Decision
  • TAIT
  • BCDA Strong Buy
  • Analyst Count
  • TAIT 0
  • BCDA 1
  • Target Price
  • TAIT N/A
  • BCDA $25.00
  • AVG Volume (30 Days)
  • TAIT 246.6K
  • BCDA 110.8K
  • Earning Date
  • TAIT 11-14-2025
  • BCDA 11-12-2025
  • Dividend Yield
  • TAIT 17.54%
  • BCDA N/A
  • EPS Growth
  • TAIT N/A
  • BCDA N/A
  • EPS
  • TAIT N/A
  • BCDA N/A
  • Revenue
  • TAIT $3,545,000.00
  • BCDA N/A
  • Revenue This Year
  • TAIT N/A
  • BCDA N/A
  • Revenue Next Year
  • TAIT N/A
  • BCDA N/A
  • P/E Ratio
  • TAIT N/A
  • BCDA N/A
  • Revenue Growth
  • TAIT N/A
  • BCDA N/A
  • 52 Week Low
  • TAIT $1.11
  • BCDA $1.00
  • 52 Week High
  • TAIT $5.10
  • BCDA $3.20
  • Technical
  • Relative Strength Index (RSI)
  • TAIT 15.89
  • BCDA 46.34
  • Support Level
  • TAIT $2.16
  • BCDA $1.25
  • Resistance Level
  • TAIT $2.28
  • BCDA $1.34
  • Average True Range (ATR)
  • TAIT 0.13
  • BCDA 0.08
  • MACD
  • TAIT -0.12
  • BCDA 0.00
  • Stochastic Oscillator
  • TAIT 0.00
  • BCDA 41.63

About TAIT Taitron Components Incorporated

Taitron Components Inc is a supplier of originally designed and manufactured (ODM) products that include value-added engineering and turn-key solutions. It focuses on providing original equipment manufacturers (OEMs) and contracts electronic manufacturers (CEMs) with ODM products for their multi-year turn-key projects and ODM electronic components. The company's product offerings range from discrete semiconductors to small electronic devices. The company also distributes brand-name electronic components with a vast inventory available on hand. Its Taiwan and China locations, provide support for inventory sourcing, purchases, and coordinating the manufacture of ODM Projects and ODM Components.

About BCDA BioCardia Inc.

BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being advanced for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an off the shelf cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).

Share on Social Networks: